Drug Discovery for Genetic Diseases Caused by Aberrant mRNA Splicing

Proceedings for Annual Meeting of The Japanese Pharmacological Society
doi 10.1254/jpssuppl.93.0_1-s10-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Aberrant Splicing and Drug Resistance in AML

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Structure-Based Drug Discovery for Tropical Diseases

Current Topics in Medicinal Chemistry
MedicineDrug Discovery
2009English

Aberrant Splicing of Tau Pre-mRNA Caused by Intronic Mutations Associated With the Inherited Dementia Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2000English

Innovative Partnerships for Drug Discovery Against Neglected Diseases

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2011English

Mammalian Tissues Defective in Nonsense-Mediated mRNA Decay Display Highly Aberrant Splicing Patterns

Genome Biology
2012English

Genetic Variation of Pre-mRNA Alternative Splicing in Human Populations

Wiley Interdisciplinary Reviews: RNA
BiochemistryMolecular Biology
2011English

Predicting the Change of Exon Splicing Caused by Genetic Variant Using Support Vector Regression

Human Mutation
Genetics
2019English

Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases

Trends in Parasitology
ParasitologyInfectious Diseases
2019English

Teach–Discover–Treat (TDT): Collaborative Computational Drug Discovery for Neglected Diseases

Journal of Molecular Graphics and Modelling
Computer GraphicsTheoretical ChemistryMaterials ChemistryComputer-Aided DesignSpectroscopyPhysical
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy